Rashid Sayyid

Title(s)Clinical Instructor of Urology (Fellow)
SchoolKeck School of Medicine of Usc
Address1450 Biggy Street
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Can the free/total psa ratio predict undetected intraductal carcinoma and cribriform pattern at biopsy? World J Urol. 2024 Nov 28; 42(1):651. Bernardino RM, Yin LB, Lajkosz K, Cockburn JG, Wettstein MS, Woon D, Nguyen DD, Sayyid R, Leão R, van der Kwast T, Fleshner N. PMID: 39607443.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Association of Free-to-Total PSA Ratio and 18F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study. J Nucl Med. 2024 Nov 01; 65(11):1731-1739. Bernardino RM, Lajkosz K, Yin LB, Sayyid RK, Wettstein M, Randhawa H, Cockburn JG, Ahmed S, Thomassian R, Diamandis E, Metser U, Berlin A, Fleshner NE. PMID: 39327019.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. The inhibition effect of psoralen on prostate cancer PC3 cells via down-regulation of long non-coding RNA ENST00000510619. Transl Androl Urol. 2024 Oct 31; 13(10):2294-2306. Chen S, Weng M, Lin R, Wei J, Zhu L, Ju Z, Lin Z, Zhan B, Pathak RA, Sayyid RK, Ge R. PMID: 39507866; PMCID: PMC11535728.
      View in: PubMed   Mentions:
    4. Profiling of urinary extracellular vesicle protein signatures from patients with cribriform and intraductal prostate carcinoma in a cross-sectional study. Sci Rep. 2024 10 23; 14(1):25065. Bernardino R, Carvalho AS, Hall MJ, Alves L, Leão R, Sayyid R, Pereira H, Beck HC, Pinheiro LC, Henrique R, Fleshner N, Matthiesen R. PMID: 39443544; PMCID: PMC11500006.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    5. Undetected Cribriform and Intraductal Prostate Cancer at biopsy is associated with adverse outcomes. Prostate Cancer Prostatic Dis. 2024 Oct 21. Bernardino RM, Yin LB, Lajkosz K, Cockburn JG, Wettstein M, Sayyid RK, Henrique R, Pinheiro LC, van der Kwast T, Fleshner NE. PMID: 39433886.
      View in: PubMed   Mentions:    Fields:    
    6. Lessons from the ACDC-RP trial: Clinical trial design for radical prostatectomy neoadjuvant therapy trials. Oncotarget. 2024 Sep 30; 15:660-661. Sayyid RK, Fleshner NE. PMID: 39347713; PMCID: PMC11441411.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Adjuvant immune checkpoint inhibitors for urothelial carcinoma: systematic review and Meta-analysis. World J Urol. 2024 Jul 18; 42(1):418. Sayyid RK, Bernardino R, Chavarriaga J, Kumar R, Randhawa H, Wettstein MS, Cockburn JG, Klaassen Z, Fleshner NE. PMID: 39023778.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Rucaparib monotherapy in the heavily pre-treated metastatic castrate-resistant prostate cancer setting: practical considerations and alternate treatment approaches. Transl Androl Urol. 2024 May 31; 13(5):884-888. Sayyid RK, Bernardino R, Chavarriaga J, Gleave A, Kumar R, Fleshner NE. PMID: 38855585; PMCID: PMC11157394.
      View in: PubMed   Mentions: 1  
    9. Hysterectomy versus chemotherapy for low-risk non-metastatic gestational trophoblastic neoplasia (GTN): A cost-effectiveness analysis. Gynecol Oncol. 2024 08; 187:30-36. Mitric C, Sayyid RK, Fleshner NE, Look Hong NJ, Bouchard-Fortier G. PMID: 38705127.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Association of extended core sampling with delayed intervention and pathologic outcomes for active surveillance patients A population-based analysis. Can Urol Assoc J. 2024 May; 18(5):E142-E151. Sayyid RK, Bernardino R, Al-Daqqaq Z, Tiwari R, Al-Rumayyan M, Sildva T, Cockburn JG, Klaassen Z, Fleshner NE. PMID: 38319602; PMCID: PMC11152595.
      View in: PubMed   Mentions:
    11. Editorial Comment on "Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy". Urology. 2024 06; 188:101-102. Klaassen Z, Kyle Cline J, Sayyid RK. PMID: 38648944.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    12. Advancing Precision Oncology With Artificial Intelligence: Ushering in the ArteraAI Prostate Test. Urology. 2024 06; 188:20-23. Ghamande SS, Cline JK, Sayyid RK, Klaassen Z. PMID: 38648952.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Using active surveillance for Gleason 7 (3+4) prostate cancer: A narrative review. Can Urol Assoc J. 2024 Apr; 18(4):135-144. Bernardino R, Sayyid RK, Leão R, Zlotta AR, van der Kwast T, Klotz L, Fleshner NE. PMID: 38381936; PMCID: PMC11034964.
      View in: PubMed   Mentions: 2  
    14. Reply by Authors. J Urol. 2024 Apr; 211(4):595. Bernardino R, Sayyid RK, Lajkosz K, Al-Daqqaq Z, Tiwari R, Cockburn J, Leão R, Metser U, Berlin A, van der Kwast T, Fleshner NE. PMID: 38382010.
      View in: PubMed   Mentions:    Fields:    
    15. Intraductal Prostate Cancer Affinity for Lymphatic-Predominant Metastases Through 18F-DCFPyL‒Prostate-Specific Membrane Antigen‒Positron Emission Tomography/CT Scans in Pretreatment Prostate Cancer Patients. J Urol. 2024 Apr; 211(4):586-593. Bernardino R, Sayyid RK, Lajkosz K, Al-Daqqaq Z, Tiwari R, Cockburn J, Leão R, Metser U, Berlin A, van der Kwast T, Fleshner NE. PMID: 38299501.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial. Clin Cancer Res. 2023 10 02; 29(19):3867-3874. Fleshner NE, Sayyid RK, Hansen AR, Chin JLK, Fernandes R, Winquist E, van der Kwast T, Sweet J, Lajkosz K, Kenk M, Hersey K, Veloso R, Berlin D, Herrera-Caceres JO, Sridhar S, Moussa M, Finelli A, Hamilton RJ, Kulkarni GS, Zlotta AR, Joshua AM. PMID: 37439809.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    17. Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer. Eur Urol Focus. 2024 Jan; 10(1):146-153. Bernardino RM, Sayyid RK, Lajkosz K, Al-Daqqaq Z, Cockburn JG, Chavarriaga J, Abedi S, Leão R, Berlin A, van der Kwast T, Fleshner NE. PMID: 37696743.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer. BJU Int. 2023 12; 132(6):638-640. Bernardino R, Sayyid RK, Leão R, Zlotta AR, van der Kwast T, Klotz L, Fleshner NE. PMID: 37606994.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Redefining surveillance strategies: innovations in testicular cancer care. Transl Androl Urol. 2023 Sep 30; 12(9):1368-1370. Chavarriaga J, Sayyid RK, Bernardino R, Kumar R, Al-Rumayyan M, Hamilton RJ. PMID: 37814697; PMCID: PMC10560341.
      View in: PubMed   Mentions:
    20. Industry Relationships in Urology: Characterizing the High-payment Urologists. Letter. J Urol. 2023 10; 210(4):586-588. Nguyen DD, Nguyen AV, Khondker A, Kwong JCC, Xuan-Lan Nguyen A, Labban M, Stone BV, Sayyid R, Bhojani N, Satkunasivam R, Trinh QD, Wallis CJD. PMID: 37530127.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Poly(adenosine diphosphate-ribose) polymerase inhibitor combinations in first-line metastatic castrate-resistant prostate cancer setting: a systematic review and meta-analysis. BJU Int. 2023 12; 132(6):619-630. Sayyid RK, Klaassen Z, Berlin A, Roy S, Brandão LR, Bernardino R, Chavarriaga J, Jiang DM, Spratt DE, Fleshner NE, Wallis CJD. PMID: 37461140.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    22. Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer. BJU Int. 2023 12; 132(6):664-670. Sayyid RK, Bernardino R, Al-Daqqaq Z, Tiwari R, Cockburn J, Vijayakanthan S, Leão R, Qaoud Y, Berjaoui MB, Metser U, Berlin A, Fleshner NE. PMID: 37433574.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Lymphotropic Pattern of Prostate-specific Membrane Antigen-detected Metastases Among Biochemically Recurrent Radical Prostatectomy Patients with Cribriform Disease. Eur Urol Focus. 2023 11; 9(6):1016-1023. Bernardino R, Sayyid RK, Al-Daqqaq Z, Tiwari R, Cockburn J, Vijayakanthan S, Qaoud Y, Berjaoui MB, Metser U, Berlin A, van der Kwast T, Fleshner NE. PMID: 37268513.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Industry Payments to American Editorial Board Members of Major Urology Journals. Eur Urol. 2023 10; 84(4):442-443. Nguyen DD, Murad L, Nguyen AX, Zorigtbaatar A, Bouhadana D, Deyirmendjian C, Zorn KC, Elterman D, Chughtai B, Sayyid RK, Labban M, Trinh QD, Wallis CJD, Bhojani N. PMID: 37127467.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Small Renal Masses: The Evolving Histologic, Imaging, and Genomic Landscapes. J Clin Med. 2023 Mar 18; 12(6). Chavarriaga J, Al-Rumayyan M, Kumar RM, Bernardino R, Sayyid RK. PMID: 36983360; PMCID: PMC10055747.
      View in: PubMed   Mentions:
    26. Urologic Oncology Survivorship Guidelines: An Overview of the Evidence and the Current Implementation Gap. Eur Urol Focus. 2023 05; 9(3):431-434. Nguyen DD, Wallis CJD, Fleshner NE, Trinh QD, Klaassen Z, Sayyid RK. PMID: 36842920.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Prostate cancer mortality rates in low- and favorable intermediate-risk active surveillance patients: a population-based competing risks analysis. World J Urol. 2023 Jan; 41(1):93-99. Sayyid RK, Benton JZ, Reed WC, Woodruff P, Terris MK, Wallis CJD, Klaassen Z. PMID: 36472651.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Editorial Comment. Urology. 2022 10; 168:108. Reed WC, Lambert JH, Sayyid RK. PMID: 36266017.
      View in: PubMed   Mentions:    Fields:    
    29. Suspension of Oncology Randomized Clinical Trials during the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related Suspensions. Cancer Invest. 2022 Oct; 40(9):743-749. Sayyid RK, Hiffa A, Woodruff P, Oberle MD, Lambert JH, Terris MK, Wallis CJD, Klaassen Z. PMID: 35852930.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    30. On the shoulders of giants: correlation of rates of female first authorship with senior authorship gender. Br J Surg. 2022 08 16; 109(9):885-886. Launer BM, Sayyid RK, Klaassen Z, Whelan E, Magee DE, Luckenbaugh AN, Wallis CJD. PMID: 35666842.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Addition of Docetaxel to Androgen Receptor Axis-targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis. Eur Urol Oncol. 2022 10; 5(5):494-502. Roy S, Sayyid R, Saad F, Sun Y, Lajkosz K, Ong M, Klaassen Z, Malone S, Spratt DE, Wallis CJD, Morgan SC. PMID: 35811293.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    32. Burnout reduction in acute care surgeons: Impact of faculty schedule change at a level 1 trauma and tertiary care center. J Trauma Acute Care Surg. 2022 10 01; 93(4):439-445. Jones CE, Fox ED, Holsten SB, White CQ, Sayyid RK, O'Keeffe T, Lawson AG. PMID: 35788582.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Multicentric experience in Retzius-sparing robot-assisted radical prostatectomy performed by expert surgeons for high-risk prostate cancer. Minerva Urol Nephrol. 2022 Oct; 74(5):607-614. Galfano A, Tappero S, Eden C, Dell'oglio P, Fransis K, Guo H, Kowalczyk K, Longoni M, Madi R, Rha KH, Secco S, Qiu X, Sayyid R, Bocciardi AM. PMID: 35708535.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    34. Active surveillance in favorable intermediate-risk prostate cancer patients: Predictors of deferred intervention and treatment choice. Can Urol Assoc J. 2022 01; 16(1):E7-E14. Sayyid RK, Klotz L, Benton JZ, Ma M, Woodruff P, Satkunasivam R, Terris MK, Wallis CJD, Klaassen Z. PMID: 34464250; PMCID: PMC8937595.
      View in: PubMed   Mentions: 4  
    35. Pudendal nerve block prior to inflatable penile prosthesis implantation: decreased intra-operative narcotic requirements. Int J Impot Res. 2023 Jun; 35(4):1-5. Sayyid RK, Taylor NS, Owens-Walton J, Oberle MD, Fratino KL, Terris MK, Klaassen Z, King SA. PMID: 34819658.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. Impact of early hypothalamic-pituitary-gonadal axis maturation on prostate cancer: cross-sectional analysis of a Veterans affairs cohort. Transl Androl Urol. 2021 Aug; 10(8):3368-3374. Khadir RM, Sayyid RK, Matthews B, King SA, Terris MK. PMID: 34532261; PMCID: PMC8421831.
      View in: PubMed   Mentions:
    37. Upgrading on radical prostatectomy specimens of very low- and low-risk prostate cancer patients on active surveillance: A population-level analysis. Can Urol Assoc J. 2021 Jul; 15(7):E335-E339. Sayyid RK, Wilson B, Benton JZ, Lodh A, Thomas EF, Goldberg H, Madi R, Terris MK, Wallis CJD, Klaassen Z. PMID: 33382372; PMCID: PMC8279242.
      View in: PubMed   Mentions: 1  
    38. Transparency of racial participation reporting in randomized controlled trials of minimally invasive surgical techniques. Surg Endosc. 2022 04; 36(4):2600-2606. Sayyid RK, Lokeshwar SD, Tella D, Jones CE, Oberle MD, Woodruff P, Klaassen Z, Wallis CJD. PMID: 33978852.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Women as Authors of Randomized Controlled Trials of Minimally Invasive Surgery: Systematic Review and Meta-Analysis of 3 Decades of Trials. J Am Coll Surg. 2021 08; 233(2):167-175.e9. Sayyid RK, Lokeshwar SD, Luckenbaugh AN, Hall ME, Jones CE, Magee DE, Hird AE, Terris MK, Klaassen Z, Wallis CJ. PMID: 33887485.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Pathologic upgrading in favorable intermediate risk active surveillance patients: Clinical heterogeneity and implications for active surveillance decision. Urol Oncol. 2021 11; 39(11):782.e7-782.e14. Sayyid RK, Reed WC, Benton JZ, Lodh A, Woodruff P, Lambert JH, Terris MK, Wallis CJD, Klaassen Z. PMID: 33766466.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Influence of Sociodemographic Factors on Definitive Intervention Among Low-risk Active Surveillance Patients. Urology. 2021 09; 155:117-123. Sayyid RK, Klotz L, Benton JZ, Lodh A, Lambert JH, Woodruff P, Lokeshwar SD, Madi R, Goldberg H, Terris MK, Wallis CJD, Klaassen Z. PMID: 33577898.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    42. Diagnostic utility of axial imaging in the evaluation of hematuria: A systematic review and critical appraisal of the literature. Can Urol Assoc J. 2021 Feb; 15(2):48-55. Wallis CJD, Sayyid RK, Manyevitch R, Perlis N, Lokeshwar VB, Fleshner NE, Terris MK, Nielsen ME, Klaassen Z. PMID: 32745004; PMCID: PMC7864718.
      View in: PubMed   Mentions: 1  
    43. Early Experience with Salvage Retzius-sparing Robotic-assisted Radical Prostatectomy: Oncologic and Functional Outcomes. Urology. 2021 03; 149:117-121. Madi R, Sayyid RK, Hiffa A, Thomas E, Terris MK, Klaassen Z. PMID: 33417926.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    44. Re-operation within 30 days of radical cystectomy: Identifying high-risk patients and complications using American College of Surgeons National Surgical Quality Improvement Program database. Can Urol Assoc J. 2021 Jan; 15(1):E1-E5. Sayyid RK, Magee D, Hird AE, Harper BT, Webb E, Fratino KL, Terris MK, Madi R, Satkunasivam R, Wallis CJD, Klaassen Z. PMID: 32701439; PMCID: PMC7769521.
      View in: PubMed   Mentions: 2  
    45. Absence of a positive outcome bias in randomized controlled trials of minimally invasive surgical techniques. J Clin Epidemiol. 2021 03; 131:163-165. Sayyid RK, Lokeshwar SD, Tella D, Jones CE, Klaassen Z, Wallis CJD. PMID: 33279688.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer. Eur Urol Focus. 2021 May; 7(3):537-545. Goldberg H, Mohsin FK, Saskin R, Kulkarni GS, Berlin A, Kenk M, Wallis CJD, Klaassen Z, Chandrasekar T, Ahmad AE, Sayyid RK, Saarela O, Penn L, Alibhai SMH, Fleshner N. PMID: 32620539.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    47. Retzius-sparing robotic-assisted laparoscopic radical prostatectomy: racial considerations for 250 consecutive cases. J Robot Surg. 2021 Apr; 15(2):221-228. Sayyid RK, Sherwood D, Simpson WG, Terris MK, Klaassen Z, Madi R. PMID: 32472391.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    48. Elevated suicide risk among patients with urologic malignancies: highlighting at-risk populations. Ann Transl Med. 2020 Mar; 8(6):272. Sayyid RK, Wallis CJD, Dymanus K, Jazzar U, Goldberg H, Williams SB, Klaassen Z. PMID: 32355716; PMCID: PMC7186707.
      View in: PubMed   Mentions:
    49. Are there differences between de novo and secondary upper tract urothelial carcinoma tumours? Can Urol Assoc J. 2019 09; 13(9):E292-E299. Goldberg H, Cheung DC, Chandrasekar T, Klaassen Z, Wallis CJD, Kulkarni GS, Sayyid R, Evans A, Masoomian M, Bapat B, van der Kwast T, Hamilton RJ, Zlotta A, Fleshner N. PMID: 30763230; PMCID: PMC6754256.
      View in: PubMed   Mentions:
    50. Cancer diagnosis and risk of suicide after accounting for prediagnosis psychiatric care: A matched-cohort study of patients with incident solid-organ malignancies. Cancer. 2019 08 15; 125(16):2886-2895. Klaassen Z, Wallis CJD, Chandrasekar T, Goldberg H, Sayyid RK, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P, Kulkarni GS. PMID: 31021430; PMCID: PMC10182898.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    51. The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies. Br J Cancer. 2019 04; 120(8):840-847. Klaassen Z, Wallis CJD, Goldberg H, Chandrasekar T, Sayyid RK, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P, Kulkarni GS. PMID: 30837680; PMCID: PMC6474265.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    52. Population-based outcomes of men with a single negative prostate biopsy: Importance of continued follow-up among older patients. Urol Oncol. 2019 05; 37(5):298.e19-298.e27. Sayyid RK, Alibhai SMH, Sutradhar R, Eberg M, Fung K, Klaassen Z, Goldberg H, Perlis N, Madi R, Terris MK, Urbach DR, Fleshner NE. PMID: 30770299.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    53. Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer. Int J Cancer. 2019 04 01; 144(7):1676-1684. Leão R, Lee D, Figueiredo A, Hermanns T, Wild P, Komosa M, Lau I, Mistry M, Nunes NM, Price AJ, Zhang C, Lipman T, Poyet C, Valtcheva N, Oehl K, Coelho H, Sayyid R, Gomes AM, Prado E Castro L, Sweet J, Vinagre J, Apolónio J, Stephens D, Faleiro I, Fadaak K, Richard PO, Kulkarni G, Zlotta AR, Hamilton RJ, Castelo-Branco P, Tabori U. PMID: 30350309; PMCID: PMC6519346.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    54. Lessons Learned from the Global Epidemiology of Kidney Cancer: A Refresher in Epidemiology 101. Eur Urol. 2019 01; 75(1):85-87. Klaassen Z, Sayyid RK, Wallis CJD. PMID: 30274700.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    55. Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 Years. J Urol. 2018 11; 200(5):1056-1061. Goldberg H, Klaassen Z, Chandrasekar T, Wallis CJD, Toi A, Sayyid R, Bhindi B, Nesbitt M, Evans A, van der Kwast T, Sweet J, Perlis N, Hamilton RJ, Kulkarni GS, Finelli A, Zlotta A, Fleshner N. PMID: 29758220.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. The Untold Advantages of Retzius-Sparing Robotic Radical Prostatectomy. J Endourol. 2018 07; 32(7):671-672. Sayyid RK, Madi R. PMID: 29790362.
      View in: PubMed   Mentions: 3     Fields:    
    57. Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis. Oncotarget. 2018 Apr 10; 9(27):18797-18810. Goldberg H, Klaassen Z, Chandrasekar T, Sayyid R, Kulkarni GS, Hamilton RJ, Fleshner NE. PMID: 29721162; PMCID: PMC5922356.
      View in: PubMed   Mentions: 3     Fields:    
    58. High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis. Oncotarget. 2018 Mar 30; 9(24):16731-16743. Chandrasekar T, Klaassen Z, Goldberg H, Sayyid RK, Kulkarni GS, Fleshner NE. PMID: 29682181; PMCID: PMC5908282.
      View in: PubMed   Mentions: 5     Fields:    
    59. Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients' and urologic oncologists' perspectives. Can Urol Assoc J. 2018 May; 12(5):E210-E218. Sayyid RK, Sayyid AK, Klaassen Z, Hersey K, Goldberg H, Perlis N, Ahmad A, Leao R, Chandrasekar T, Fadaak K, Madi R, Terris MK, Finelli A, Hamilton RJ, Kulkarni GS, Zlotta AR, Fleshner NE. PMID: 29405907; PMCID: PMC5966932.
      View in: PubMed   Mentions: 2  
    60. Changing Trends for Suicidal Death in Patients With Bladder Cancer: A 40+ Year Population-level Analysis. Clin Genitourin Cancer. 2018 06; 16(3):206-212.e1. Klaassen Z, Goldberg H, Chandrasekar T, Arora K, Sayyid RK, Hamilton RJ, Fleshner NE, Williams SB, Wallis CJD, Kulkarni GS. PMID: 29395948.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    61. Retzius-Sparing Robotic-Assisted Laparoscopic Radical Prostatectomy: A Safe Surgical Technique with Superior Continence Outcomes. J Endourol. 2017 12; 31(12):1244-1250. Sayyid RK, Simpson WG, Lu C, Terris MK, Klaassen Z, Madi R. PMID: 28859492.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    62. Defining a Cohort that May Not Require Repeat Prostate Biopsy Based on PCA3 Score and Magnetic Resonance Imaging: The Dual Negative Effect. J Urol. 2018 05; 199(5):1182-1187. Perlis N, Al-Kasab T, Ahmad A, Goldberg E, Fadak K, Sayyid R, Finelli A, Kulkarni G, Hamilton R, Zlotta A, Ghai S, Fleshner N. PMID: 29175542.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    63. Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines. J Urol. 2018 04; 199(4):906-914. Klaassen Z, Arora K, Goldberg H, Chandrasekar T, Wallis CJD, Sayyid RK, Fleshner NE, Finelli A, Kutikov A, Violette PD, Kulkarni GS. PMID: 29113840.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    64. Lymphadenectomy in Gleason 7 prostate cancer: Adherence to guidelines and effect on clinical outcomes. Urol Oncol. 2018 01; 36(1):13.e11-13.e18. Chandrasekar T, Goldberg H, Klaassen Z, Sayyid RK, Hamilton RJ, Fleshner NE, Kulkarni GS. PMID: 28919181.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Testosterone Responders to Continuous Androgen Deprivation Therapy Show Considerable Variations in Testosterone Levels on Followup: Implications for Clinical Practice. J Urol. 2018 01; 199(1):251-256. Sayyid RK, Sayyid AK, Klaassen Z, Fadaak K, Goldberg H, Chandrasekar T, Ahmad A, Leao R, Perlis N, Chadwick K, Hamilton RJ, Kulkarni GS, Finelli A, Zlotta AR, Fleshner NE. PMID: 28751266.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    66. What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy? Can Urol Assoc J. 2017 Mar-Apr; 11(3-4):118-122. Sayyid RK, Dingar D, Fleshner K, Thorburn T, Diamond J, Yao E, Hersey K, Chadwick K, Perlis N, Klotz L, Finelli A, Hamilton R, Kulkarni G, Zlotta A, Fleshner N. PMID: 28458749; PMCID: PMC5403625.
      View in: PubMed   Mentions: 2  
    67. Development and external validation of a biopsy-derived nomogram to predict risk of ipsilateral extraprostatic extension. BJU Int. 2017 07; 120(1):76-82. Sayyid R, Perlis N, Ahmad A, Evans A, Toi A, Horrigan M, Finelli A, Zlotta A, Kulkarni G, Hamilton R, Morash C, Fleshner N. PMID: 27930844.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    68. A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy. Clin Cancer Res. 2017 04 15; 23(8):1974-1980. Sayyid RK, Evans A, Hersey K, Maloni R, Hurtado-Coll A, Kulkarni G, Finelli A, Zlotta AR, Hamilton R, Gleave M, Fleshner NE. PMID: 27756786.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    69. Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance. J Urol. 2017 01; 197(1):75-83. Perlis N, Sayyid R, Evans A, Van Der Kwast T, Toi A, Finelli A, Kulkarni G, Hamilton R, Zlotta AR, Trachtenberg J, Ghai S, Fleshner NE. PMID: 27457260.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    70. Potential role for metformin in urologic oncology. Investig Clin Urol. 2016 05; 57(3):157-64. Sayyid RK, Fleshner NE. PMID: 27195314; PMCID: PMC4869570.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    71. Diabetes Mellitus Type 2: A Driving Force for Urological Complications. Trends Endocrinol Metab. 2016 05; 27(5):249-261. Sayyid RK, Fleshner NE. PMID: 26969242.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    72. Renal hilar paraganglioma: A case report. World J Radiol. 2014 Jan 28; 6(1):15-7. Yehia ZA, Sayyid RK, Haydar AA. PMID: 24578788; PMCID: PMC3936207.
      View in: PubMed   Mentions: 1  
    Rashid's Networks
    Concepts (207)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.